NASDAQ · BIS

ProShares UltraShort NASDAQ Biotechnology (BIS)

$11.15−0.95%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$11.15▼ 58.27% in range
Sep 29, 2025Low $10.53 · High $33.89Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

ProShares UltraShort NASDAQ Biotechnology closed at $11.15 on Sep 28, down 0.95%, 67.1% below its 52-week closing high. Volume of 10.7K shares was 1.64× its 20-day average (above normal).

Split-adjusted performance: +4.0% over one month, -43.2% over six months, -60.4% over one year.

Short interest was 5.6K shares at the Sep 15 settlement, down 4.1% from the prior report (1.0 days to cover).

Market cap$1.8M165.5K shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yield4.98%$0.1389 last paid
52-week range10.53 – 33.89−67.1% from high
Volume10.7K1.64× 20-day avg
Volatility · 60d48.1%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W −3.3%1M +4.0%3M −18.1%6M −43.2%YTD −41.2%1Y −60.4%3Y −75.0%5Y −67.0%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short5.6K−4.1% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d48.2%of daily volume

News about ProShares UltraShort NASDAQ Biotechnology

All news →

No recent articles focused on ProShares UltraShort NASDAQ Biotechnology.

Quick answers

What is BIS's market cap?
$1.85M, based on the Sep 28 close of $11.15.
Does ProShares UltraShort NASDAQ Biotechnology pay a dividend?
Yes. The latest regular dividend was $0.1389 per share (ex-date Sep 23), an annualised yield of 4.98%.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology